About Us
Excellence in Science coupled with Multinational Discovery and Development Experience
Abiosciences is a biotechnology company with a global vision founded in 2018. With innovation based on cutting-edge science as our key driving principle, we are committed to accelerate breakthrough discoveries and
first-in-class therapeutics.
By fully applying our scientific research strengths and single-cell big data platform with intellectual property rights, we create accurate cell atlases of human diseases and generate new knowledge and insights for the identification and validation of novel targets and biomarkers. This helps our partners develop next-generation breakthrough therapeutics and diagnostics.
Since inception, we have rapidly attracted high-level entrepreneurial talent, assembling effective senior leadership and world-class R&D teams. We have opened R&D sites in Beijing, Shanghai, and South San Francisco, expanding our footprint to major markets in the world.
Our Antibody R&D Center focuses on innate immunity and tumor microenvironment regulation research. Based on our innovative drug development platform, we have quickly obtained a panel of new targets with high potential for drug discovery as well as antibody assets ready for partners to take forward in their development programs.
Meet Our Team
We have seasoned leaders with collectively over 120 years of experience in biotech, pharma, diagnostic, and life science industries.
